Details

NACI Rapid Response interim guidance on the use of Imvamune in the context of monkeypox outbreaks (mpox) in Canada, CCDR 48(7/8) - Canada.ca

Metadata and links for an archived snapshot.

Source: Public Health Agency of Canada
Date: Feb 19, 2026 · edition #7
Timestamp: 2026-02-19T01:18:24.937Z
Language: en
Original URL: https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2022-48/issue-7-8-july-august-2022/summary-national-advisory-committee-immunization-naci-rapid-response-interim-guidance-imvamune-monkeypox-outbreaks-canada.html
Replay URL: https://replay.healtharchive.ca/job-7/20260219011824/https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2022-48/issue-7-8-july-august-2022/summary-national-advisory-committee-immunization-naci-rapid-response-interim-guidance-imvamune-monkeypox-outbreaks-canada.html#ha_snapshot=923675
ID: 923675
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots